IN SILICO STUDY OF IODINATED 5,10,15,20-TETRAKIS(4-AMINOPHENYL) PORPHYRIN AS RADIOPHARMACEUTICALS CANDIDATE FOR CHRONIC MYELOID LEUKEMIA THERAPY AGAINST BCR-ABL1T315I
5,10,15,20-tetrakis(4-aminophenyl) porphyrin (TAPP) is a porphyrin-derived compound that has potential as a radiopharmaceutical ligand. TAPP labeled with the radionuclide Iodine-131 can be used as a therapeutic candidate for chronic myeloid leukemia (CML) cancer. CML is caused by the expression...
Saved in:
Main Author: | Kurniawan, Michael |
---|---|
Format: | Final Project |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/74253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
POTENCY OF IODINATED 5,10,15,20-TETRAKIS(4-AMINOPHENYL) PORPHYRIN AS RADIOPHARMACEUTICALS FOR CHRONIC MYELOID LEUKEMIA: IN SILICO STUDY
by: Kurniawan, Michael -
OPTIMIZATION OF LABELING CONDITIONS 5,10,15,20 - TETRAKIS (P-AMINOPHENYL) PORPHYRIN (TAPP) WITH IODINE USING THE CHLORAMINE-T
by: Wiranata Sibuea, Aswin -
Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias
by: Nicolini, F.E., et al.
Published: (2016) -
Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
by: Koh, Yanqing.
Published: (2011) -
Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants
by: C. U. Auewarakul, et al.
Published: (2018)